Novartis's corporate venturing unit leads the round for the diagnostic imaging company which was set up by UCLA faculty in 2007.

Novartis's corporate venturing unit leads the round for the diagnostic imaging company which was set up by UCLA faculty in 2007.

Azelon Pharmaceuticals, an osteoporosis treatment company, previously backed by GlaxoSmithKline's SR One before a restructuring, reportedly raises $5.2m in a round, which followed a reshuffling of its leaders of the company.

Leerink Swann wins the co-lead role alongside Citigroup and Morgan Stanley after backing the company's series B last year.

The healthcare research company backed by healthcare company Merck's corporate venturing unit does the deal after selling a majority stake to a buyout firm last year.

Abingdon will use the money to buy 50.1% of Molecular Vision, another Imperial Innovations portfolio company, as well as for other projects, including those from its Bioscience Ventures joint venture with the University of Birmingham.

Novo helps Apollo Endosurgery raise $47.6m.

The US-based medical diagnostics company has spun off a plastics company with in partnership with a Chinese province, which its chief executive says could be a $1bn opportunity.

Anaphore said it acquired RuiYi for an undisclosed amount to gain access to its biologics drug discovery platform targeting G protein coupled receptors (GPCRs).